Volgen
Viggo Van Tendeloo
Viggo Van Tendeloo
University of Antwerp
Geverifieerd e-mailadres voor uza.be
Titel
Geciteerd door
Geciteerd door
Jaar
Clinical use of dendritic cells for cancer therapy
S Anguille, EL Smits, E Lion, VF van Tendeloo, ZN Berneman
The lancet oncology 15 (7), e257-e267, 2014
8012014
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid …
VFI Van Tendeloo, P Ponsaerts, F Lardon, G Nijs, M Lenjou, ...
Blood, The Journal of the American Society of Hematology 98 (1), 49-56, 2001
6702001
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination
VF Van Tendeloo, A Van de Velde, A Van Driessche, N Cools, S Anguille, ...
Proceedings of the National Academy of Sciences 107 (31), 13824-13829, 2010
4822010
CD56 in the immune system: more than a marker for cytotoxicity?
HH Van Acker, A Capsomidis, EL Smits, VF Van Tendeloo
Frontiers in immunology 8, 892, 2017
3912017
Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells
N Cools, P Ponsaerts, VFI Van Tendeloo, ZN Berneman
Journal of Leucocyte Biology 82 (6), 1365-1374, 2007
3852007
Regulatory T cells and human disease
N Cools, P Ponsaerts, VFI Van Tendeloo, ZN Berneman
Journal of Immunology Research 2007 (1), 089195, 2007
3182007
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy
ELJM Smits, P Ponsaerts, ZN Berneman, VFI Van Tendeloo
The oncologist 13 (8), 859-875, 2008
2772008
mRNA-based gene transfer as a tool for gene and cell therapy.
VF Van Tendeloo, P Ponsaerts, ZN Berneman
Current opinion in molecular therapeutics 9 (5), 423-431, 2007
2402007
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
S Anguille, AL Van de Velde, EL Smits, VF Van Tendeloo, G Juliusson, ...
Blood, The Journal of the American Society of Hematology 130 (15), 1713-1721, 2017
2192017
Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia
S Anguille, VF Van Tendeloo, ZN Berneman
Leukemia 26 (10), 2186-2196, 2012
2192012
Cancer immunotherapy using RNA-loaded dendritic cells
P Ponsaerts, VFI Van Tendeloo, ZN Berneman
Clinical & Experimental Immunology 134 (3), 378-384, 2003
2182003
Bisphosphonates for cancer treatment: mechanisms of action and lessons from clinical trials
HH Van Acker, S Anguille, Y Willemen, EL Smits, VF Van Tendeloo
Pharmacology & therapeutics 158, 24-40, 2016
2172016
A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile
EMF Van Craenenbroeck, CJ Vrints, SE Haine, K Vermeulen, I Goovaerts, ...
Journal of applied physiology 104 (4), 1006-1013, 2008
2072008
Dendritic cells as pharmacological tools for cancer immunotherapy
S Anguille, EL Smits, C Bryant, HH Van Acker, H Goossens, E Lion, ...
Pharmacological reviews 67 (4), 731-753, 2015
1822015
Natural killer cell immune escape in acute myeloid leukemia
E Lion, Y Willemen, ZN Berneman, VFI Van Tendeloo, ELJ Smits
Leukemia 26 (9), 2019-2026, 2012
1782012
Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied
SH Van Ierssel, EM Van Craenenbroeck, VM Conraads, VF Van Tendeloo, ...
Thrombosis research 125 (4), 332-339, 2010
1512010
Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor-but not monocyte-derived …
VFI Van Tendeloo, HW Snoeck, F Lardon, GLEE Vanham, G Nijs, ...
Gene Therapy 5 (5), 700-707, 1998
1491998
RNA-based gene transfer for adult stem cells and T cells
E Smits, P Ponsaerts, M Lenjou, G Nijs, DR Van Bockstaele, ...
Leukemia 18 (11), 1898-1902, 2004
1482004
Efficient genetic modification of murine dendritic cells by electroporation with mRNA
S Van Meirvenne, L Straetman, C Heirman, M Dullaers, C De Greef, ...
Cancer gene therapy 9 (9), 787-797, 2002
1462002
Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation …
A Van Driessche, ALR Van de Velde, G Nijs, T Braeckman, B Stein, ...
Cytotherapy 11 (5), 653-668, 2009
1412009
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20